Renaissance Technologies
MEDS

Renaissance Technologies’s DataMeds AI MEDS Stock Holding History

Renaissance Technologies’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-204
Closed -$9.88K – 4036
2025
Q2 		$9.88K Buy
+204
New +$28.1K ﹤0.01% 3507

Other funds holding MEDS

HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $667M AUM 45.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VFIC
Valley Forge Investment Consultants Audubon, Pennsylvania $388M AUM 22.18% 1-Year Est. Return

Renaissance Technologies's MEDS Position: Q3 2025 in Review

Renaissance Technologies sold out of DataMeds AI (MEDS) in Q3 2025, closing a stake of 204 shares — an estimated $9.88K sold.

Renaissance Technologies first reported a position in MEDS in Q2 2025 and held it in 1 quarter. The position peaked at $9.88K in Q2 2025. 15 funds tracked by Wall St. Rank hold MEDS as of Q3 2025.

  • Renaissance Technologies reported no remaining DataMeds AI position as of Q3 2025 after selling out during the quarter.
  • Renaissance Technologies sold 204 DataMeds AI shares in Q3 2025, an estimated $9.88K.
  • Renaissance Technologies first reported a position in DataMeds AI in Q2 2025 and held it in 1 quarter.
  • Renaissance Technologies's DataMeds AI position peaked at $9.88K in Q2 2025.
  • 15 funds tracked by Wall St. Rank held DataMeds AI as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.